Allison Portnoy | Profiles RNS

Allison Portnoy, ScD

Assistant Professor

Boston University School of Public Health

Global Health

ScD, Harvard School of Public Health

Pronouns: she/her/hers

Websites

ORCID : 0000-0002-8467-1324

Dr. Allison Portnoy is an assistant professor of global health focused on vaccine decision science and policy. Her research includes economic evaluation and public health policy, simulation modeling, health equity, and the impact of vaccination on population health and economic outcomes. She is particularly interested in broadening the value of vaccination in high-burden settings. Her ongoing work spans multiple diseases areas, including human papillomavirus (HPV), measles, and tuberculosis (TB).

Dr. Portnoy received a Doctor of Science from the Department of Global Health and Population and completed a postdoctoral fellowship at the Center for Health Decision Science, both at the Harvard T.H. Chan School of Public Health. Her previous education includes an MSPH in Health Policy & Management from the Johns Hopkins Bloomberg School of Public Health and a BA in International Relations from Stanford University. She previously worked as a health economist at the International Vaccine Access Center at Johns Hopkins, and conducted research projects with the World Health Organization, Agency for Healthcare Research and Quality, and the University of Washington in Seattle.

BU Research

Vaccine Impact Modelling Consortium (VIMC) 2.0
07/01/2023 - 08/31/2027 (Subcontract PI)
Imperial College Gavi Vaccine Ally

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Hartner AM, Li X, Echeverria-Londono S, Roth J, Abbas K, Auzenbergs M, de Villiers MJ, Ferrari MJ, Fraser K, Fu H, Hallett T, Hinsley W, Jit M, Karachaliou A, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Minh QT, Vynnycky E, Winter AK, Burrows H, Chen C, Clapham HE, Deshpande A, Hauryski S, Huber J, Jean K, Kim C, Kim JH, Koh J, Lopman BA, Pitzer VE, Tam Y, Lambach P, Sim SY, Woodruff K, Ferguson NM, Trotter CL, Gaythorpe KAM. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study. Lancet Glob Health. 2024 Apr; 12(4):e563-e571. PMID: 38485425; PMCID: PMC10951961; DOI: 10.1016/S2214-109X(23)00603-4;

Sumner T, Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Bakker R, Scarponi D, Hatherill M, Menzies NA, White RG. Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa. Vaccine. 2024 Feb 27; 42(6):1311-1318. PMID: 38307747

Portnoy A, Pedersen K, Sy S, Tropé A, Engesaeter B, Kim JJ, Burger EA. Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis. Int J Cancer. 2024 Mar 15; 154(6):1073-1081. PMID: 38088449; DOI: 10.1002/ijc.34804;

Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, Hatcher C, Hsu CH, Ho LL, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Bose AS, Caro WP, O'Connor P, Crowcroft NS. Progress Toward Measles Elimination - Worldwide, 2000-2022. MMWR Morb Mortal Wkly Rep. 2023 Nov 17; 72(46):1262-1268. PMID: 37971951; PMCID: PMC10684353; DOI: 10.15585/mmwr.mm7246a3;

Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, Hatcher C, Hsu CH, Ho LL, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Bose AS, Caro WP, O'Connor P, Crowcroft NS. Progress Toward Measles Elimination - Worldwide, 2000-2022. MMWR Morb Mortal Wkly Rep. 2023; 46(72):1262-1268. View Publication

Portnoy A, Yamanaka T, Nguhiu P, Nishikiori N, Garcia Baena I, Floyd K, Menzies NA. Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis. Lancet Glob Health. 2023 Oct; 11(10):e1640-e1647. PMID: 37734806; PMCID: PMC10522775; DOI: 10.1016/S2214-109X(23)00369-8;

Prem K, Choi YH, Bénard É, Burger EA, Hadley L, Laprise JF, Regan MC, Drolet M, Sy S, Abbas K, Portnoy A, Kim JJ, Brisson M, Jit M. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis. BMC Med. 2023 Aug 28; 21(1):313. PMID: 37635227; PMCID: PMC10463590; DOI: 10.1186/s12916-023-02988-3;

Sbarra AN, Jit M, Mosser JF, Ferrari M, Cutts F, Papania M, Kretsinger K, McCarthy KA, Thakkar N, Gaythorpe KAM, Gamage D, Krause LK, Dansereau E, Crowcroft N, Portnoy A. Population-Level Risk Factors Related to Measles Case Fatality: A Conceptual Framework Based on Expert Consultation and Literature Review. Vaccines (Basel). 2023 Aug 21; 11(8). PMID: 37631957; PMCID: PMC10458804; DOI: 10.3390/vaccines11081389;

Clark RA, Weerasuriya CK, Portnoy A, Mukandavire C, Quaife M, Bakker R, Scarponi D, Harris RC, Rade K, Mattoo SK, Tumu D, Menzies NA, White RG. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination. BMC Med. 2023 Aug 04; 21(1):288. PMID: 37542319; PMCID: PMC10403932; DOI: 10.1186/s12916-023-02992-7;

Portnoy A, Arcand JL, Clark RA, Weerasuriya CK, Mukandavire C, Bakker R, Patouillard E, Gebreselassie N, Zignol M, Jit M, White RG, Menzies NA. The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. PLoS Med. 2023 Jul; 20(7):e1004252. PMID: 37432972; PMCID: PMC10335702; DOI: 10.1371/journal.pmed.1004252;

Showing 10 of 51 results. Show More

Portnoy A, Clark RA, Weerasuriya CK, Mukandavire C, Quaife M, Bakker R, Garcia Baena I, Gebreselassie N, Zignol M, Jit M, White RG, Menzies NA. The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries. BMJ Glob Health. 2023 Jul; 8(7). PMID: 37438049; PMCID: PMC10347450; DOI: 10.1136/bmjgh-2023-012466;

Sbarra AN, Mosser JF, Jit M, Ferrari M, Ramshaw RE, O'Connor P, Krause LK, Rogowski ELB, Portnoy A. Estimating national-level measles case-fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study. Lancet Glob Health. 2023 Apr; 11(4):e516-e524. PMID: 36925172; PMCID: PMC10030458; DOI: 10.1016/S2214-109X(23)00043-8;

Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Deol A, Scarponi D, Iskauskas A, Bakker R, Quaife M, Malhotra S, Gebreselassie N, Zignol M, Hutubessy RCW, Giersing B, Jit M, Harris RC, Menzies NA, White RG. The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2023 Apr; 11(4):e546-e555. PMID: 36925175; PMCID: PMC10030455; DOI: 10.1016/S2214-109X(23)00045-1;

Portnoy A, Clark RA, Quaife M, Weerasuriya CK, Mukandavire C, Bakker R, Deol AK, Malhotra S, Gebreselassie N, Zignol M, Sim SY, Hutubessy RCW, Baena IG, Nishikiori N, Jit M, White RG, Menzies NA. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. PLoS Med. 2023 Jan; 20(1):e1004155. PMID: 36693081; PMCID: PMC9873163; DOI: 10.1371/journal.pmed.1004155;

Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, Hauryski S, Hatcher C, Nedelec Y, Datta D, Ho LL, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Bose AS, Perea WA, O'Connor P. Progress Toward Regional Measles Elimination - Worldwide, 2000-2021. MMWR Morb Mortal Wkly Rep. 2022 Nov 25; 71(47):1489-1495. PMID: 36417303; PMCID: PMC9707362; DOI: 10.15585/mmwr.mm7147a1;

Echeverria-Londono S, Hartner AM, Li X, Roth J, Portnoy A, Sbarra AN, Abbas K, Ferrari M, Fu H, Jit M, Ferguson NM, Gaythorpe KAM. Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa. Vaccine. 2022 Nov 08; 40(47):6806-6817. PMID: 36244882; DOI: 10.1016/j.vaccine.2022.09.049;

Ahmed Ali H, Hartner AM, Echeverria-Londono S, Roth J, Li X, Abbas K, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, Toor J, Gaythorpe KAM. Correction: Vaccine equity in low and middle income countries: a systematic review and meta-analysis. Int J Equity Health. 2022 Jul 07; 21(1):92. PMID: 35799250; PMCID: PMC9264635; DOI: 10.1186/s12939-022-01695-4;

Ali HA, Hartner AM, Echeverria-Londono S, Roth J, Li X, Abbas K, Portnoy A, Vynnycky E, Woodruff K, Ferguson NM, Toor J, Gaythorpe KA. Vaccine equity in low and middle income countries: a systematic review and meta-analysis. Int J Equity Health. 2022 Jun 11; 21(1):82. PMID: 35701823; PMCID: PMC9194352; DOI: 10.1186/s12939-022-01678-5;

Toor J, Li X, Jit M, Trotter CL, Echeverria-Londono S, Hartner AM, Roth J, Portnoy A, Abbas K, Ferguson NM, Am Gaythorpe K. COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery. Vaccine. 2022 Jul 29; 40(31):4142-4149. PMID: 35672179; PMCID: PMC9148934; DOI: 10.1016/j.vaccine.2022.05.074;

Portnoy A, Hsieh YL, Abbas K, Klepac P, Santos H, Brenzel L, Jit M, Ferrari M. Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling study. BMC Med. 2022 Mar 09; 20(1):113. PMID: 35260139; PMCID: PMC8904070; DOI: 10.1186/s12916-022-02242-2;

Portnoy A, Pedersen K, Nygård M, Trogstad L, Kim JJ, Burger EA. Identifying a Single Optimal Integrated Cervical Cancer Prevention Policy in Norway: A Cost-Effectiveness Analysis. Med Decis Making. 2022 Aug; 42(6):795-807. PMID: 35255741; DOI: 10.1177/0272989X221082683;

Sediqzadah S, Portnoy A, Kim JJ, Keshavan M, Pandya A. Cost-Effectiveness of Early Intervention in Psychosis: A Modeling Study. Psychiatr Serv. 2022 Sep 01; 73(9):970-977. PMID: 35193372; DOI: 10.1176/appi.ps.202100161;

Portnoy A, Nygård M, Trogstad L, Kim JJ, Burger EA. Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in Norway. MDM Policy Pract. 2022; 7(1):23814683211071093. PMID: 35024449; PMCID: PMC8744166; DOI: 10.1177/23814683211071093;

Fu H, Abbas K, Klepac P, van Zandvoort K, Tanvir H, Portnoy A, Jit M. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries. BMC Med. 2021 Nov 17; 19(1):281. PMID: 34784922; PMCID: PMC8594955; DOI: 10.1186/s12916-021-02157-4;

Dixon MG, Ferrari M, Antoni S, Li X, Portnoy A, Lambert B, Hauryski S, Hatcher C, Nedelec Y, Patel M, Alexander JP, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Bose AS, Rosewell A, Kretsinger K, Crowcroft NS. Progress Toward Regional Measles Elimination - Worldwide, 2000-2020. MMWR Morb Mortal Wkly Rep. 2021 Nov 12; 70(45):1563-1569. PMID: 34758014; PMCID: PMC8580203; DOI: 10.15585/mmwr.mm7045a1;

Pedersen K, Portnoy A, Sy S, Hansen BT, Tropé A, Kim JJ, Burger EA. Switching clinic-based cervical cancer screening programs to human papillomavirus self-sampling: A cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women. Int J Cancer. 2022 Feb 01; 150(3):491-501. PMID: 34664271; DOI: 10.1002/ijc.33850;

Portnoy A, Menzies NA. Financing sustainable health systems for the next decade. Lancet. 2021 Nov 20; 398(10314):1852-1853. PMID: 34742370; DOI: 10.1016/S0140-6736(21)01828-6;

Portnoy A, Abbas K, Sweet S, Kim JJ, Jit M. Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study. BMJ Glob Health. 2021 Nov; 6(11). PMID: 34725040; PMCID: PMC8562528; DOI: 10.1136/bmjgh-2021-006940;

Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, Smith MA, Sy S, Nygård M, Kim JJ, Burger EA. Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation. Prev Med. 2021 Sep; 150:106688. PMID: 34303489; DOI: 10.1016/j.ypmed.2021.106688;

Toor J, Echeverria-Londono S, Li X, Abbas K, Carter ED, Clapham HE, Clark A, de Villiers MJ, Eilertson K, Ferrari M, Gamkrelidze I, Hallett TB, Hinsley WR, Hogan D, Huber JH, Jackson ML, Jean K, Jit M, Karachaliou A, Klepac P, Kraay A, Lessler J, Li X, Lopman BA, Mengistu T, Metcalf CJE, Moore SM, Nayagam S, Papadopoulos T, Perkins TA, Portnoy A, Razavi H, Razavi-Shearer D, Resch S, Sanderson C, Sweet S, Tam Y, Tanvir H, Tran Minh Q, Trotter CL, Truelove SA, Vynnycky E, Walker N, Winter A, Woodruff K, Ferguson NM, Gaythorpe KA. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. Elife. 2021 Jul 13; 10. PMID: 34253291; PMCID: PMC8277373; DOI: 10.7554/eLife.67635;

Banks C, Portnoy A, Moi F, Boonstoppel L, Brenzel L, Resch SC. Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic. Vaccine. 2021 Aug 16; 39(35):5046-5054. PMID: 34325935; PMCID: PMC8238647; DOI: 10.1016/j.vaccine.2021.06.076;

Portnoy A, Sweet S, Desalegn D, Memirie ST, Kim JJ, Verguet S. Health gains and financial protection from human papillomavirus vaccination in Ethiopia: findings from a modelling study. Health Policy Plan. 2021 Jun 25; 36(6):891-899. PMID: 33942850; PMCID: PMC8227995; DOI: 10.1093/heapol/czab052;

Uy J, Ketkar AG, Portnoy A, Kim JJ. Cost-utility analysis of heart surgeries for young adults with severe rheumatic mitral valve disease in India. Int J Cardiol. 2021 Sep 01; 338:50-57. PMID: 34090957; DOI: 10.1016/j.ijcard.2021.05.059;

Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, Smith MA, Sy S, Nygård M, Kim JJ, Burger EA. Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis. Prev Med. 2021 Mar; 144:106276. PMID: 33678239; DOI: 10.1016/j.ypmed.2020.106276;

Mezei A, Cohen J, Renwick MJ, Atwell J, Portnoy A. Mathematical modelling of respiratory syncytial virus (RSV) in low- and middle-income countries: A systematic review. Epidemics. 2021 Jun; 35:100444. PMID: 33662812; PMCID: PMC8262087; DOI: 10.1016/j.epidem.2021.100444;

Portnoy A, Resch SC, Suharlim C, Brenzel L, Menzies NA. What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries. Value Health. 2021 Jan; 24(1):67-69. PMID: 33431155; PMCID: PMC7813212; DOI: 10.1016/j.jval.2020.08.2097;

Portnoy A, Vaughan K, Clarke-Deelder E, Suharlim C, Resch SC, Brenzel L, Menzies NA. Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates. Pharmacoeconomics. 2020 Sep; 38(9):995-1005. PMID: 32596785; PMCID: PMC7437655; DOI: 10.1007/s40273-020-00930-6;

Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries. Int J Cancer. 2021 Feb 15; 148(4):932-940. PMID: 32706907; DOI: 10.1002/ijc.33233;

Portnoy A, Jit M, Helleringer S, Verguet S. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries. Value Health. 2020 Jul; 23(7):891-897. PMID: 32762991; PMCID: PMC7519803; DOI: 10.1016/j.jval.2020.03.012;

Portnoy A, Clark S, Ozawa S, Jit M. The impact of vaccination on gender equity: conceptual framework and human papillomavirus (HPV) vaccine case study. Int J Equity Health. 2020 Jan 14; 19(1):10. PMID: 31937328; PMCID: PMC6961353; DOI: 10.1186/s12939-019-1090-3;

Munk C, Portnoy A, Suharlim C, Clarke-Deelder E, Brenzel L, Resch SC, Menzies NA. Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries. BMC Health Serv Res. 2019 Oct 22; 19(1):741. PMID: 31640687; PMCID: PMC6806517; DOI: 10.1186/s12913-019-4468-4;

Portnoy A, Jit M, Ferrari M, Hanson M, Brenzel L, Verguet S. Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis. Lancet Glob Health. 2019 Apr; 7(4):e472-e481. PMID: 30797735; PMCID: PMC6418190; DOI: 10.1016/S2214-109X(18)30537-0;

Portnoy A, Jit M, Helleringer S, Verguet S. Impact of measles supplementary immunization activities on reaching children missed by routine programs. Vaccine. 2018 Jan 02; 36(1):170-178. PMID: 29174680; PMCID: PMC5949217; DOI: 10.1016/j.vaccine.2017.10.080;

Ozawa S, Clark S, Portnoy A, Grewal S, Stack ML, Sinha A, Mirelman A, Franklin H, Friberg IK, Tam Y, Walker N, Clark A, Ferrari M, Suraratdecha C, Sweet S, Goldie SJ, Garske T, Li M, Hansen PM, Johnson HL, Walker D. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020. Bull World Health Organ. 2017 Sep 01; 95(9):629-638. PMID: 28867843; PMCID: PMC5578376; DOI: 10.2471/BLT.16.178475;

Haidari LA, Brown ST, Constenla D, Zenkov E, Ferguson M, de Broucker G, Ozawa S, Clark S, Portnoy A, Lee BY. Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique. Sex Transm Dis. 2017 Apr; 44(4):222-226. PMID: 28282648; PMCID: PMC5547744; DOI: 10.1097/OLQ.0000000000000574;

Ozawa S, Grewal S, Portnoy A, Sinha A, Arilotta R, Stack ML, Brenzel L. Funding gap for immunization across 94 low- and middle-income countries. Vaccine. 2016 Dec 07; 34(50):6408-6416. PMID: 28029541; PMCID: PMC5142419; DOI: 10.1016/j.vaccine.2016.09.036;

Ozawa S, Portnoy A, Getaneh H, Clark S, Knoll M, Bishai D, Yang HK, Patwardhan PD. Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States. Health Aff (Millwood). 2016 Nov 01; 35(11):2124-2132. PMID: 27733424; DOI: 10.1377/hlthaff.2016.0462;

Ozawa S, Clark S, Portnoy A, Grewal S, Brenzel L, Walker DG. Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20. Health Aff (Millwood). 2016 Feb; 35(2):199-207. PMID: 26858370; DOI: 10.1377/hlthaff.2015.1086;

Portnoy A, Ozawa S, Grewal S, Norman BA, Rajgopal J, Gorham KM, Haidari LA, Brown ST, Lee BY. Costs of vaccine programs across 94 low- and middle-income countries. Vaccine. 2015 May 07; 33 Suppl 1:A99-108. PMID: 25919184; DOI: 10.1016/j.vaccine.2014.12.037;

Portnoy A, Jit M, Lauer J, Blommaert A, Ozawa S, Stack M, Murray J, Hutubessy R. Estimating costs of care for meningitis infections in low- and middle-income countries. Vaccine. 2015 May 07; 33 Suppl 1:A240-7. PMID: 25919168; DOI: 10.1016/j.vaccine.2014.11.061;

Jit M, Brisson M, Portnoy A, Hutubessy R. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health. 2014 Jul; 2(7):e406-14. PMID: 25103394; DOI: 10.1016/S2214-109X(14)70237-2;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 51 publications over 10 distinct years, with a maximum of 12 publications in 2021 and 2023

Bar chart showing 51 publications over 10 distinct years, with a maximum of 12 publications in 2021 and 2023

Year	Publications
2014	1
2015	2
2016	3
2017	3
2019	2
2020	5
2021	12
2022	9
2023	12
2024	2

Tweets
Twitter Likes

Tweets by allisonportnoy?lang=en

Twitter likes by allisonportnoy?lang=en

2023 International Papillomavirus Society: Early Career Recognition Award

2019 Harvard T.H. Chan School of Public Health: Clarence James and Sarah Bradley Gamble Scholarship

2019 Harvard T.H. Chan School of Public Health: Michael von Clemm Traveling Fellowship

2018 Harvard T.H. Chan School of Public Health: Uwe Brinkmann Memorial Travel Fellowship

2013 The National Board of Public Health Examiners: Certified in Public Health

2013 Johns Hopkins Bloomberg School of Public Health: Certificate in Vaccine Science and Policy

Contact for Mentoring:

801 Massachusetts Ave
Boston MA 02118
Google Map

617.358.0041

Download vCard

Portnoy's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (107) concept(s)

Similar People

See all (60) people

Same Department

Search Department